Notogen Inc.

Notogen Inc. is a biotechnology startup that is making waves in the health care and life sciences industries with its pioneering approach to regenerative therapy. The company, founded in 2016 and based in Toronto, Canada, is focused on addressing degenerative disc disease, a widespread issue causing chronic back and neck pain. Their novel biologic regenerative therapy, currently in the pre-clinical stage and undergoing cGMP manufacturing, aims to provide a fast, cost-effective, and minimally invasive solution for patients. This injectable solution has the potential to arrest degeneration, repair and regenerate spinal disc tissues, and alleviate pain and inflammation, offering hope to millions worldwide. With a robust foundation built on over 20 years of clinical and laboratory research, Notogen is poised to make a significant impact in the field of regenerative medicine.